Skip to content

An exploratory study on poor prognostic factors for patients with resected body-tail adenocarcinoma of the pancreas.

An exploratory study on poor prognostic factors for patients with resected body-tail adenocarcinoma of the pancreas. - Poor prognostic factors for pancreatic body-tail adenocarcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000032225
Enrollment
300
Registered
2018-04-27
Start date
2018-07-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic adenocarcinoma

Interventions

None listed

Sponsors

Sapporo Medical University
Lead Sponsor
Hokkaido Pancreatic Cancer study Group
Collaborator
HOPS
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Pathologically proven pancreatic adenocarcinoma 2. Patients who underwent radical resection 3. Patients who accept to participate in this research

Exclusion criteria

Exclusion criteria: Patients judged inappropriate as research subjects by research managers

Design outcomes

Primary

MeasureTime frame
Overall survival (OS)

Secondary

MeasureTime frame
Disease free survival (DFS) Poor prognostic factors for OS

Countries

Japan

Contacts

Public ContactYasutoshi Kimura

Sapporo Medical University School of Medicine Department of Surgery, Surgical Oncology and Science

kimuray@sapmed.ac.jp011-611-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026